← Leaderboards
Michael Cardone
Eutropics Pharmaceuticals, Inc.
$3,199,381
Attributed
$3,199,381
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2012–14$2M$1.5M$1M$500K$0
'12
'13
'14
Funding mix
By agency
NIH$3,199,381 · 3
By mechanism
N44$2,999,489 · 2
N43$199,892 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Agreement”
- David R. Weir · University Of Michigan At Ann Arbor$324,662,245
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Gary D Acton · University Of California-Davis$320,373,312
- Bruce Clements · Texas State Dept Of Health Services$239,415,715
- Barton F Haynes · Duke University$214,674,926
- Ethan Schreier · Associated Universities, Inc.$206,468,864
Research focus
AgreementSamplingCollaborationsCancer CenterResponseMitochondriaTreatment StrategyAdverse EffectsContractsProtocols DocumentationBone MarrowCancer CellBiopsyTreatment EfficacyStandard CareBiomarkerPharmacologic SubstanceDiagnosticLeukemia, Myelocytic, AcuteCompanionsPositioning AttributeTechnologyCategoriesBiobank
Grant awards (3)
IGF::CT::IGF DEVELOPMENT OF PRAEDICARE DX AS CDX FOR AMLPERIOD OF PERFORMANCE: SEPTEMBER 19, 2014 THROUGH SEPTEMBER 18, 2015$1,499,743
N44 · FY2014 · CA · contact PI
OTHER FUNCTIONS TOPIC 277, DEVELOPING BH3 PROFILING AS A COMPANION DIAGNOSTIC FO$1,499,746
N44 · FY2012 · CA · contact PI
OTHER FUNCTIONS R&D- BIOMEDICAL (BASIC RESEARCH)$199,892
N43 · FY2012 · CA · contact PI